| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d174c2face13443300694bb3a9a95c4 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2015-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23f6a9821a340f21f2c481d4dccf95c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbd08065fb94ecb208d08feadcdfdb97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ab44073fbbe766bcc9e2ab8c0b188f4 |
| publicationDate |
2016-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
UA-105586-U |
| titleOfInvention |
METHOD OF TREATMENT OF Hepatic Encephalopathy |
| abstract |
A method for treating hepatic encephalopathy involves the use of basic therapy. Additionally, choline alfoscerate (Gliatilin) is prescribed in 4 ml each (1 ampoule contains 1000 mg of choline alfoscerate) intravenously daily No. 10. Then, patients continue to take the drug in capsules of 800 mg / day for 1 month. |
| priorityDate |
2015-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |